Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.
Company profile
Ticker
MDT, MDT-MM
Exchange
Website
CEO
Geoffrey Martha
Employees
Location
Fiscal year end
Industry (SIC)
Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical • Fonar ...
Former names
Medtronic Holdings Ltd, Medtronic Ltd
SEC CIK
Corporate docs
Subsidiaries
2074417 Alberta ULC • A&E Products de Honduras S.A. • A&E Products do Brasil Ltda. • A&E Products Group, Inc. • Advanced Medical Technologies GmbH • Affera, Inc. • AI Biomed Corp • Aircraft Medical Ltd. • Airox, Inc. • Arterial Vascular Engineering Canada, Company ...
MDT stock data
Latest filings (excl ownership)
10-Q
2024 Q3
Quarterly report
27 Feb 24
8-K
Medtronic reports third quarter
20 Feb 24
S-8
Registration of securities for employees
8 Dec 23
8-K
Other Events
6 Dec 23
10-Q
2024 Q2
Quarterly report
30 Nov 23
8-K
Medtronic reports second quarter
21 Nov 23
8-K
Departure of Directors or Certain Officers
23 Oct 23
ARS
2023 FY
Annual report to shareholders
13 Sep 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
31 Aug 23
10-Q
2024 Q1
Quarterly report
31 Aug 23
Transcripts
MDT
Earnings call transcript
2024 Q3
20 Feb 24
MDT
Earnings call transcript
2024 Q2
21 Nov 23
MDT
Earnings call transcript
2024 Q1
22 Aug 23
MDT
Earnings call transcript
2023 Q4
25 May 23
MDT
Earnings call transcript
2023 Q3
21 Feb 23
MDT
Earnings call transcript
2023 Q2
22 Nov 22
MDT
Earnings call transcript
2023 Q1
23 Aug 22
MDT
Earnings call transcript
2022 Q4
26 May 22
MDT
Earnings call transcript
2022 Q3
22 Feb 22
MDT
Earnings call transcript
2022 Q2
23 Nov 21
Latest ownership filings
4
Michael Marinaro
9 Apr 24
4
Michael Marinaro
7 Mar 24
4
Sean Salmon
23 Feb 24
144
Notice of proposed sale of securities
21 Feb 24
5
Orchestra BioMed Holdings, Inc.
14 Feb 24
SC 13G/A
Orchestra BioMed Holdings, Inc.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
12 Feb 24
4
Jennifer M Kirk
2 Feb 24
4
Brett A. Wall
20 Dec 23
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Apr 23 | Apr 22 | Apr 21 | Apr 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.31 bn | 1.31 bn | 1.31 bn | 1.31 bn | 1.31 bn | 1.31 bn |
Cash burn (monthly) | 9.33 mm | 293.08 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 53.97 mm | 1.69 bn | n/a | n/a | n/a | n/a |
Cash remaining | 1.26 bn | -383.69 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 134.7 | -1.3 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2023
57.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1670 |
Opened positions | 211 |
Closed positions | 413 |
Increased positions | 521 |
Reduced positions | 801 |
13F shares | Current |
---|---|
Total value | 57.89 tn |
Total shares | 757.11 mm |
Total puts | 1.91 mm |
Total calls | 1.16 mm |
Total put/call ratio | 1.6 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 126.55 mm | $10.43 tn |
STT State Street | 60.92 mm | $5.06 tn |
Massachusetts Financial Services | 28.89 mm | $2.38 tn |
Capital Research Global Investors | 28.84 mm | $2.38 tn |
JPM JPMorgan Chase & Co. | 25.39 mm | $2.09 tn |
Wellington Management | 24.01 mm | $1.98 tn |
MS Morgan Stanley | 23.28 mm | $1.92 tn |
BK Bank Of New York Mellon | 21.09 mm | $1.74 tn |
BEN Franklin Resources | 19.36 mm | $1.60 tn |
T. Rowe Price | 15.40 mm | $1.27 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Apr 24 | Michael Marinaro | Ordinary Shares | Sell | Dispose S | No | No | 83.14 | 854 | 71.00 k | 27,925 |
5 Mar 24 | Michael Marinaro | Ordinary Shares | Payment of exercise | Dispose F | No | No | 83.6 | 563 | 47.07 k | 28,779 |
1 Feb 24 | Kirk Jennifer M | Ordinary Shares | Payment of exercise | Dispose F | No | No | 88.09 | 1,159 | 102.10 k | 13,208 |
19 Dec 23 | Brett A. Wall | Ordinary Shares | Sell | Dispose S | No | Yes | 82.17 | 4,997 | 410.60 k | 28,910 |
13 Apr 23 | Medtronic | Common Stock | Grant | Acquire A | Yes | No | 0 | 869,493 | 0.00 | 5,868,916 |
News
Looking Into Medtronic's Recent Short Interest
18 Apr 24
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
15 Apr 24
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
10 Apr 24
Medtronic Announced Evolut Tavr Platform Met Both Co-primary Endpoints Of Clinical Non-inferiority And Hemodynamic Superiority At One Year
7 Apr 24
10 Health Care Stocks Whale Activity In Today's Session
4 Apr 24
Press releases
The Value Unlocker: Why Ed Breen Makes Investors Money
17 Apr 24
Americans favor quality over quantity in pursuit of longevity
17 Apr 24
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
10 Apr 24
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
10 Apr 24
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
9 Apr 24